Logiscreen

Lantheus Holdings Inc

$100.98
Market Cap 6.52B
ROE 24.3%
Gross Margin 61.2%
Debt/Equity 0.5
Current Ratio 2.8
Revenue QoQ 1.2%
EPS QoQ 0.7%
F-Score 8

About

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
23.81
vs median 33.61
P/B
5.48
vs median 2.16
ROE
0.24
vs median 0.09

High quality company with strong fundamentals

Mid-cap company with growth potential

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics